NRT Smoking Cessation Aids in Germany
Euromonitor International's NRT Smoking Cessation Aids in Germany market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 46 | Publication date: Aug 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
OTC HEALTHCARE IN GERMANY : MARKET INSIGHT
EXECUTIVE SUMMARY
Stagnating sales in 2006
Ageing population requires more medical care
Distribution system under fire
Market concentration continues
KEY TRENDS AND DEVELOPMENTS
Demographics: Increasing life expectancy creates additional demand
Increasing health awareness of German consumers
German distribution system under fire
Switching activity
Market concentration continues
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2001-2006
Table 2 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 5 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 6 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 7 Penetration of Private Label by Sector 2002-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Vitamins and dietary supplements registration and classification
Generics
Consumer expenditure on health goods and medical services
Table 12 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - GERMANY
BAYER AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Bayer HealthCare AG: Key Facts
Summary 3 Bayer HealthCare: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Bayer AG: Competitive Position 2006
BEIERSDORF AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Beiersdorf AG: Key Facts
Summary 6 Beiersdorf AG: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Beiersdorf AG: Competitive Position 2006
BOEHRINGER SOHN, CH - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
Summary 9 Boehringer Sohn CH: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Boehringer Sohn CH: Competitive Position 2006
GLAXOSMITHKLINE PLC - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 11 GlaxoSmithKline GmbH & Co KG: Key Facts
Summary 12 GlaxoSmithKline Plc: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 GlaxoSmithKline Plc: Competitive Position 2006
JOHNSON & JOHNSON INC - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Johnson & Johnson GmbH: Key Facts
Summary 15 Johnson & Johnson Inc: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 Johnson & Johnson Inc: Competitive Position 2006
MCM KLOSTERFRAU VERTRIEBSGESELLSCHAFT MBH - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 17 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 18 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2006
NOVARTIS AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 19 Novartis Deutschland GmbH: Key Facts
Summary 20 Novartis AG: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 21 Novartis AG: Competitive Position 2006
RATIOPHARM GMBH & CO - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 22 Ratiopharm GmbH & Co: Key Facts
Summary 23 Ratiopharm GmbH & Co: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 24 Ratiopharm GmbH & Co: Competitive Position 2006
STADA ARZNEIMITTEL AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 25 Stada Arzneimittel AG: Key Facts
Summary 26 Stada Arzneimittel AG: Operational Indicators (Global)
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 27 Stada Arzneimittel AG: Competitive Position 2006
NRT SMOKING CESSATION AIDS IN GERMANY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 13 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 14 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 15 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 16 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 17 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 19 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011